Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: Validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram

Journal of Clinical Pathology

Volumn 67, Issue 2, 2014, Pages 112-119

  Chue, Koy Min ^a   Yong, Wei Sean ^b   Thike, Aye Aye ^c   Ahmed, Syed Salahuddin ^c   Li, Hui Hua ^c   Wong, Chow Yin ^c   Ho, Gay Hui ^b   Madhukumar, Preetha ^b   Tan, Benita Kiat Tee ^c   Ong, Kong Wee ^b   Tan, Puay Hoon ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER CENTER; ETHNICITY; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; NOMOGRAM; NON SENTINEL LYMPH NODE METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; SINGAPORE; TUMOR VOLUME; VERY ELDERLY; WIDE EXCISION; YOUNG ADULT;

EID: 84893637609     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2013-201524     Document Type: Article

References (36)

1. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7. (Pubitemid 27270119)
2. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53. (Pubitemid 36951366)
3. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998;339:941-6. (Pubitemid 28455095)
4. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50. (Pubitemid 27251137)
5. Intra M, Rotmensz N, Mattar D, et al. Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer (Oxford, England: 1990) 2007;43:2664-8.
6. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010;251:595-600.
7. Unal B, Gur AS, Kayiran O, et al. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system. Int J Clin Pract 2008;62:1785-91.
8. Giuliano AE, Haigh PI, Brennan MB, et al. Turner RR Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553-9. (Pubitemid 30432521)
9. Alran S, De Rycke Y, Fourchotte V, et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy. Ann Surg Oncol 2007;14:2195-201. (Pubitemid 47174905)
10. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg (Chicago, Ill: 1960) 2003;138:52-6.
11. Joslyn SA, Konety BR. Effect of axillary lymphadenectomy on breast carcinoma survival. Breast Cancer Res Treat 2005;91:11-18. (Pubitemid 40684934)
12. Martelli G, Miceli R, Costa A, et al. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Cancer 2008;112:481-8. (Pubitemid 351186188)
13. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival - a Bayesian meta-analysis. Ann Surg Oncol 1999;6:109-16. (Pubitemid 29077496)
14. Yi M, Giordano SH, Meric-Bernstam F, et al. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 2010;17(Suppl 3):343-51.
15. Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001;182:316-20. (Pubitemid 33079078)
16. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6. (Pubitemid 29269240)
17. Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-81. (Pubitemid 30640103)
18. Coutant C, Olivier C, Lambaudie E, et al. Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. J Clin Oncol 2009;27:2800-8.
19. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-51. (Pubitemid 40486808)
20. Tan EY, Ho B, Chen JJ, et al. Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes. ISRN Oncol 2011:539503.doi:10.5402/2011/539503
21. Yong WS, Wong CY, Lee JS, et al. Single institution's initial experience with sentinel lymph node biopsy in breast cancer patients. ANZ J Surg 2003;73:416-21. (Pubitemid 36897823)
22. Singletary SE, Allred C, Ashley P, et al. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual. Surg Clin North Am 2003;83:803-19. (Pubitemid 36841911)
23. Weaver DL. Pathology evaluation of sentinel lymph nodes in breast cancer: protocol recommendations and rationale. Mod Pathol 2010;23:S26-32.
24. Keshtgar MR, Ell PJ. Clinical role of sentinel-lymph-node biopsy in breast cancer. Lancet Oncol 2002;3:105-10. (Pubitemid 34162981)
25. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006;106:4-16. (Pubitemid 43033320)
26. Coufal O, Pavlik T, Fabian P, et al. Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population? Pathol Oncol Res 2009;15:733-40.
27. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543-50. (Pubitemid 41306072)
28. Klar M, Jochmann A, Foeldi M, et al. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 2008;112:523-31.
29. Moghaddam Y, Falzon M, Fulford L, et al. Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg 2010;97:1646-52.
30. Smidt ML, Kuster DM, van der Wilt GJ, et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005;12:1066-72. (Pubitemid 41660683)
31. Soni NK, Carmalt HL, Gillett DJ, et al. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 2005;31:958-64. (Pubitemid 41671108)
32. van la Parra RF, Ernst MF, Bevilacqua JL, et al. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol 2009;16:1128-35.
33. Ban EJ, Lee JS, Koo JS, et al. How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer? J Breast Cancer 2011;14:296-300.
34. Lynch MA, Jackson J, Kim JA, et al. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer. Surgery 2008;144:525-31; discussion 531-522.
35. Woznick A, Franco M, Bendick P, et al. Sentinel lymph node dissection for breast cancer: how many nodes are enough and which technique is optimal? Am J Surg 2006;191:330-3. (Pubitemid 43266000)
36. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426-33.